• Tom Shaughnessy
    Crossroads regains compliance with the #Nasdaq , excellent news and execution by the company and Eberwein. $CRDS
    4/8/14
    Reply (3)
    • Rohan Mulgaonkar: Great write-ups on CRDS. I'm long at $2.37. If you get a chance, check out HERO. I averaged in at $4.40 or so. 50%+ appreciation potential.
      4/8/14
    • Steven Couche: Thinking about buying here again, would love another shot at $2
      4/8/14
    • Tom Shaughnessy: Thank you Rohan, I will check out $HERO as well. Gettin'Long, you and me both!
      4/13/14